financetom
Business
financetom
/
Business
/
Federal Prosecutors Seek 40 to 50 Year Jail Term for Convicted FTX Boss Sam Bankman-Fried
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Federal Prosecutors Seek 40 to 50 Year Jail Term for Convicted FTX Boss Sam Bankman-Fried
Mar 15, 2024 1:26 PM

04:09 PM EDT, 03/15/2024 (MT Newswires) -- Federal prosecutors want Sam Bankman-Fried to spend between 40 to 50 years in prison, according to court documents filed on Friday.

Bankman-Fried was convicted Nov. 2 on seven counts, including wire fraud and conspiracy to commit securities and commodities fraud, for his role in the collapse of FTX Trading and its affiliated Alameda Research. He was accused of using the cryptocurrency brokerage to misappropriate at least $8 billion of investor funds.

"Justice requires that he receive a prison sentence commensurate with the extraordinary dimensions of his crimes," the US government wrote in its sentence.

Bankman-Fried's lawyers previously have argued he should go to prison for 63 to 78 months, contending he did not set out to steal and many investors still may get their money back. Sentencing hearing is scheduled for March 28 in US District Court for the Southern District of New York.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Canopy Growth Down 7.5% Premarket After Reporting Wider Q1 Loss on Lower Revenue
Canopy Growth Down 7.5% Premarket After Reporting Wider Q1 Loss on Lower Revenue
Aug 9, 2024
08:35 AM EDT, 08/09/2024 (MT Newswires) -- Canopy Growth ( CGC ) fell 7.5% in premarket Nasdaq trade on Friday after the cannabis company said its first-quarter loss widened on lower revenue. The company said it lost $127.14 million, or $1.60 per share, in the quarter ended June 30, compared with a loss of $38.12 million, or $0.69, in the...
AlTi Global's Q2 Swings to Net Loss, Revenue Falls
AlTi Global's Q2 Swings to Net Loss, Revenue Falls
Aug 9, 2024
08:45 AM EDT, 08/09/2024 (MT Newswires) -- AlTi Global ( ALTI ) reported a Q2 net loss Friday of $0.18 per diluted share, swinging from earnings of $0.25 a year earlier. Revenue for the quarter ended June 30 was $49.5 million, down from $51.3 million a year earlier. One analyst surveyed by Capital IQ expected $51.8 million. Shares of the...
China Evergrande's liquidators ask investors to join restructuring process
China Evergrande's liquidators ask investors to join restructuring process
Aug 9, 2024
(Reuters) - Liquidators of heavily indebted property developer China Evergrande ( EGRNF ) said on Friday it is open to hearing from investors interested in restructuring the company or its parts. Given the property developer's high debt and business challenges, the liquidators do not currently see a path to restructuring that would allow Evergrande to resume trading of its shares,...
Avidity Biosciences Says Del-zota Shows 'Significant' Dystrophin Production in Phase 1/2 Study
Avidity Biosciences Says Del-zota Shows 'Significant' Dystrophin Production in Phase 1/2 Study
Aug 9, 2024
08:42 AM EDT, 08/09/2024 (MT Newswires) -- Avidity Biosciences ( RNA ) said Friday that AOC 1044, or delpacibart zotadirsen or del-zota, showed a 25% increase of normal in dystrophin production and a 37% increase in exon 44 skipping in a phase 1/2 trial in people living with Duchenne muscular dystrophy. The company also said that del-zota reduced creatine kinase...
Copyright 2023-2026 - www.financetom.com All Rights Reserved